Terlipressin Acetate
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB02638 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | open-angle glaucoma | KG + DL |
| 2 | primary hereditary glaucoma | KG + DL |
| 3 | pulmonary hypertension | KG + DL |
| 4 | kyphoscoliotic heart disease | KG + DL |
| 5 | esotropia | KG + DL |
| 6 | glaucoma 1, open angle | KG + DL |
| 7 | headache disorder | KG + DL |
| 8 | hyperthyroidism | KG + DL |
| 9 | glaucoma | KG + DL |
| 10 | trigeminal autonomic cephalalgia | KG + DL |
| 11 | open angle glaucoma | KG + DL |
| 12 | peripheral vascular disease | KG + DL |
| 13 | pulmonary hypertension, primary, autosomal recessive | KG + DL |
| 14 | resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta | KG + DL |
| 15 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 16 | peripheral arterial disease | KG + DL |
| 17 | cor pulmonale | KG + DL |
| 18 | Axenfeld anomaly | KG + DL |
| 19 | obsolete patella aplasia, coxa vara, and tarsal synostosis | KG + DL |
| 20 | familial clubfoot due to 17q23.1q23.2 microduplication | KG + DL |
| 21 | gastrin secretion abnormality | KG + DL |
| 22 | malignant catarrh | KG + DL |
| 23 | infectious bovine rhinotracheitis | KG + DL |
| 24 | chromosome 17q23.1-q23.2 deletion syndrome | KG + DL |
| 25 | cytomegalovirus infection | KG + DL |
| 26 | intermittent vascular claudication | KG + DL |
| 27 | Graves disease | KG + DL |
| 28 | female breast carcinoma | KG + DL |
| 29 | pulmonary hypertension, primary | KG + DL |
| 30 | coxopodopatellar syndrome | KG + DL |
| 31 | idiopathic pulmonary arterial hypertension | KG + DL |
| 32 | vitamin deficiency disorder | KG + DL |
| 33 | non-syndromic esophageal malformation | KG + DL |
| 34 | gastrointestinal hamartoma | KG + DL |
| 35 | biotin metabolic disease | KG + DL |
| 36 | intracranial arteriosclerosis | KG + DL |
| 37 | Raynaud disease | KG + DL |
| 38 | congenital hypotrichosis milia | KG + DL |
| 39 | hyperthyroxinemia | KG + DL |
| 40 | esophageal disease | KG + DL |
| 41 | pulmonary arterial hypertension | KG + DL |
| 42 | thyrotoxicosis | KG + DL |
| 43 | idiopathic and/or familial pulmonary arterial hypertension | KG + DL |
| 44 | ischemic disease | KG + DL |
| 45 | diffuse alopecia areata | KG + DL |
| 46 | amenorrhea (disease) | KG + DL |
| 47 | vascular ectasia | KG + DL |
| 48 | Ambras type hypertrichosis universalis congenita | KG + DL |
| 49 | hypotrichosis simplex of the scalp | KG + DL |
| 50 | abnormality of glucagon secretion | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.